Erratum
In the original publication of this article [1], Table 3 is incorrect, several cell values in column 4 (no ESA (n = 8)) have been incorrectly shifted during typesetting.
In this Erratum the correct and incorrect version of Table 3 are published.
Anzeige
The publisher apologizes for the inconvenience caused by this error to the authors and readers.
Table 1
Incorrect version of Table 3 as published on 26 July 2017. The incorrect cells are displayed in italics
Hb >10 g/dL | Hb ≤10 g/dL |
p-value | |||||
|---|---|---|---|---|---|---|---|
no ESA (n = 63) | ESA ≤40 μg/w (n = 75) | ESA >40 μg/w (n = 41) | no ESA (n = 8) | ESA ≤40 μg/w (n = 25) | ESA >40 μg/w (n = 28) | ||
Age (years) | 67.8 ± 15.3 | 67.1 ± 16.2 | 69.9 ± 15.4 | 74.5 ± 8.1 | 64.8 ± 17.6 | 65.9 ± 18.3 | 0.63 |
Gender (male) | 61.9% | 58.7% | 41.5% | 62.5% | 64.0% | 42.9% | 0.19 |
Diabetes | 44.4% | 41.3% | 43.9% | 37.5% | 48.0% | 35.7% | 0.96 |
Hemoglobin (g/dL) | 11.6 ± 0.9 | 11.2 ± 0.8 | 11.1 ± 0.8 | 9.6 ± 0.6 | 9.5 ± 0.4 | 9.0 ± 0.9 | <0.001 |
TSAT (%) | 29.2 ± 13.5 | 23.5 ± 9.2 | 22.7 ± 11.1 | 45.8 ± 27.4 | 25.6 ± 9.8 | 20.1 ± 17.4 | <0.001 |
Ferritin (ng/mL) | 480 ± 330 | 426 ± 285 | 473 ± 304 |
1341 ± 1541
| 636 ± 314 | 677 ± 901 | <0.001 |
Albumin (g/L) | 38.4 ± 4.4 | 39.2 ± 4.1 | 37.5 ± 4.8 | 37.8 ± 4.6 | 33.0 ± 7.8 | <0.001 | |
β2 microglobulin (mg/L) | 26.2 ± 7.0 | 25.7 ± 6.9 | 27.4 ± 8.2 |
34.1 ± 6.4
| 25.6 ± 6.2 | 27.4 ± 7.0 | 0.008 |
Parathormone (pg/mL) | 268 ± 318 | 284 ± 315 | 195 ± 207 |
35.8 ± 9.8
| 264 ± 354 | 237 ± 438 | 0.83 |
Predialysis creatinine (μmol/L) | 764 ± 282 | 769 ± 242 | 684 ± 250 |
224 ± 299
| 757 ± 220 | 638 ± 239 | 0.08 |
Predialysis urea (mmol/L) | 20.8 ± 5.9 | 21.7 ± 6.7 | 20.0 ± 6.5 |
623 ± 153
| 21.0 ± 6.1 | 19.6 ± 8.3 | 0.39 |
C-reactive protein (mg/L) | 12.2 ± 18.9 | 12.7 ± 28.4 | 26.0 ± 67.4 |
17.2 ± 5.5
| 23.1 ± 49.9 | 36.5 ± 37.1 | 0.02 |
IAA (μmol/L) | 5.10 ± 5.28 | 5.73 ± 5.97 | 3.51 ± 3.50 |
51.9 ± 97.3
| 4.67 ± 3.05 | 3.78 ± 2.60 | 0.09 |
IS (μmol/L) | 92.8 ± 54.7 | 97.9 ± 45.2 | 100.9 ± 49.9 |
2.29 ± 1.30
| 85.2 ± 55.5 | 82.3 ± 61.9 | 0.54 |
PCS(μmol/L) | 169 ± 101 | 172 ± 94 | 150 ± 97 |
78.1 ± 37.6
| 175 ± 98 | 96 ± 99 | 0.01 |
Iron medication | |||||||
IV iron medication | 54.0% | 68.0% | 73.2% |
135 ± 75
| 48.0% | 64.3% | 0.10 |
Iron dose (mg/mo) | 175 ± 188 | 228 ± 245 | 351 ± 318 | 163 ± 292 | 124 ± 167 | 314 ± 374 | 0.002 |
HDF (%) | 54.0% | 30.7% | 31.7% | 50.0% | 52.0% | 46.4% | 0.05 |
Kt/V | 1.51 ± 0.26 | 1.50 ± 0.28 | 1.50 ± 0.42 | 1.46 ± 0.30 | 1.57 ± 0.26 | 1.51 ± 0.34 | 0.95 |
Table 2
Correct version of Table 3, the corrected cells are displayed in bold
Hb >10 g/dL | Hb ≤10 g/dL |
p-value | |||||
|---|---|---|---|---|---|---|---|
no ESA (n = 63) | ESA ≤40 μg/w (n = 75) | ESA >40 μg/w (n = 41) | no ESA (n = 8) | ESA ≤40 μg/w (n = 25) | ESA >40 μg/w (n = 28) | ||
Age (years) | 67.8 ± 15.3 | 67.1 ± 16.2 | 69.9 ± 15.4 | 74.5 ± 8.1 | 64.8 ± 17.6 | 65.9 ± 18.3 | 0.63 |
Gender (male) | 61.9% | 58.7% | 41.5% | 62.5% | 64.0% | 42.9% | 0.19 |
Diabetes | 44.4% | 41.3% | 43.9% | 37.5% | 48.0% | 35.7% | 0.96 |
Hemoglobin (g/dL) | 11.6 ± 0.9 | 11.2 ± 0.8 | 11.1 ± 0.8 | 9.6 ± 0.6 | 9.5 ± 0.4 | 9.0 ± 0.9 | <0.001 |
TSAT (%) | 29.2 ± 13.5 | 23.5 ± 9.2 | 22.7 ± 11.1 | 45.8 ± 27.4 | 25.6 ± 9.8 | 20.1 ± 17.4 | <0.001 |
Ferritin (ng/mL) | 480 ± 330 | 426 ± 285 | 473 ± 304 |
1341 ± 1541
| 636 ± 314 | 677 ± 901 | <0.001 |
Albumin (g/L) | 38.4 ± 4.4 | 39.2 ± 4.1 | 37.5 ± 4.8 |
34.1 ± 6.4
| 37.8 ± 4.6 | 33.0 ± 7.8 | <0.001 |
β2 microglobulin (mg/L) | 26.2 ± 7.0 | 25.7 ± 6.9 | 27.4 ± 8.2 |
35.8 ± 9.8
| 25.6 ± 6.2 | 27.4 ± 7.0 | 0.008 |
Parathormone (pg/mL) | 268 ± 318 | 284 ± 315 | 195 ± 207 |
224 ± 299
| 264 ± 354 | 237 ± 438 | 0.83 |
Predialysis creatinine (μmol/L) | 764 ± 282 | 769 ± 242 | 684 ± 250 |
623 ± 153
| 757 ± 220 | 638 ± 239 | 0.08 |
Predialysis urea (mmol/L) | 20.8 ± 5.9 | 21.7 ± 6.7 | 20.0 ± 6.5 |
17.2 ± 5.5
| 21.0 ± 6.1 | 19.6 ± 8.3 | 0.39 |
C-reactive protein (mg/L) | 12.2 ± 18.9 | 12.7 ± 28.4 | 26.0 ± 67.4 |
51.9 ± 97.3
| 23.1 ± 49.9 | 36.5 ± 37.1 | 0.02 |
IAA (μmol/L) | 5.10 ± 5.28 | 5.73 ± 5.97 | 3.51 ± 3.50 |
2.29 ± 1.30
| 4.67 ± 3.05 | 3.78 ± 2.60 | 0.09 |
IS (μmol/L) | 92.8 ± 54.7 | 97.9 ± 45.2 | 100.9 ± 49.9 |
78.1 ± 37.6
| 85.2 ± 55.5 | 82.3 ± 61.9 | 0.54 |
PCS(μmol/L) | 169 ± 101 | 172 ± 94 | 150 ± 97 |
135 ± 75
| 175 ± 98 | 96 ± 99 | 0.01 |
Iron medication | |||||||
IV iron medication | 54.0% | 68.0% | 73.2% |
37.5%
| 48.0% | 64.3% | 0.10 |
Iron dose (mg/mo) | 175 ± 188 | 228 ± 245 | 351 ± 318 | 163 ± 292 | 124 ± 167 | 314 ± 374 | 0.002 |
HDF (%) | 54.0% | 30.7% | 31.7% | 50.0% | 52.0% | 46.4% | 0.05 |
Kt/V | 1.51 ± 0.26 | 1.50 ± 0.28 | 1.50 ± 0.42 | 1.46 ± 0.30 | 1.57 ± 0.26 | 1.51 ± 0.34 | 0.95 |
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.